Candidemia in COVID‐19 treated with corticosteroids and tocilizumab

COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment.

Detalles Bibliográficos
Autores principales: Yamamoto, Koichiro, Nakamura, Kaoru, Hagiya, Hideharu, Otsuka, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455967/
https://www.ncbi.nlm.nih.gov/pubmed/34584718
http://dx.doi.org/10.1002/ccr3.4858
_version_ 1784570775683989504
author Yamamoto, Koichiro
Nakamura, Kaoru
Hagiya, Hideharu
Otsuka, Fumio
author_facet Yamamoto, Koichiro
Nakamura, Kaoru
Hagiya, Hideharu
Otsuka, Fumio
author_sort Yamamoto, Koichiro
collection PubMed
description COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment.
format Online
Article
Text
id pubmed-8455967
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84559672021-09-27 Candidemia in COVID‐19 treated with corticosteroids and tocilizumab Yamamoto, Koichiro Nakamura, Kaoru Hagiya, Hideharu Otsuka, Fumio Clin Case Rep Clinical Images COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment. John Wiley and Sons Inc. 2021-09-21 /pmc/articles/PMC8455967/ /pubmed/34584718 http://dx.doi.org/10.1002/ccr3.4858 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Images
Yamamoto, Koichiro
Nakamura, Kaoru
Hagiya, Hideharu
Otsuka, Fumio
Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
title Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
title_full Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
title_fullStr Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
title_full_unstemmed Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
title_short Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
title_sort candidemia in covid‐19 treated with corticosteroids and tocilizumab
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455967/
https://www.ncbi.nlm.nih.gov/pubmed/34584718
http://dx.doi.org/10.1002/ccr3.4858
work_keys_str_mv AT yamamotokoichiro candidemiaincovid19treatedwithcorticosteroidsandtocilizumab
AT nakamurakaoru candidemiaincovid19treatedwithcorticosteroidsandtocilizumab
AT hagiyahideharu candidemiaincovid19treatedwithcorticosteroidsandtocilizumab
AT otsukafumio candidemiaincovid19treatedwithcorticosteroidsandtocilizumab

Ejemplares similares